Longevity

Function Health Raises $298M at $2.5B Valuation, Lowers Pricing

Function Health, the longevity-focused telehealth platform co-founded by Dr. Mark Hyman, is officially a unicorn.

Hims & Hers Enters Blood Testing Amid Preventive Health Surge

Hims & Hers has launched Labs, a subscription diagnostic service offering blood testing as consumers face rising healthcare costs.

Longevity Spending Will Transform the Global Economy, UBS Predicts

UBS says longevity is the next big growth story, as aging, wellness and innovation merge into an $8 trillion global economy by 2030.

Love.Life Aims To Put Everything You Need for Longevity Under One Roof

Co-founded by Whole Foods' John Mackey, Love.Life offers everything from advanced medical diagnostics to cold plunges and gym equipment .

Apple Watch displays the Zori AI assistant

Fountain Life Links AI-Powered Health App to All Major Wearables

Fountain Life, the Tony Robbins co-founded longevity brand, is bringing its AI-driven tech to wrists and smartphones everywhere.

White House

HFA Backs Trump’s GLP-1 Medicare Expansion, Urges Exercise Coverage

The Health & Fitness Association has praised the expansion of Medicare to cover GLP-1 drugs and calls for the coverage of exercise programs.

entrance at Prenuvo's NYC location

Hone Health Adds Prenuvo Whole-Body MRI Scans in Longevity Play

Hone Health has teamed with Prenuvo to integrate the latter's full-body MRI scans into Hone's longevity-focused telehealth platform.

Smile House Aims To Disrupt Dental Care With Longevity Services

New York City residents now have a go-to location for integrated dental care and wellness, with the opening of Smile House in Tribeca.

Joel Kocher at DKR-Texas Memorial Stadium

CEO Corner: Humann’s Joel Kocher on Reframing the Conversation Around Cardiovascular Health

One of the top former executives at Dell, Kocher founded Humann with a bold mission: change the trajectory of cardiovascular health.

GLP-1 Use Doubles Across America — Here’s Who’s Taking Them

New Gallup data shows GLP-1 use has doubled nationwide as telehealth startups and investors are reshaping the weight-loss market.